Famotidine
- Product NDC
- 72603-171
- 11-digit product format
- 726030171
- Labeler code
- 72603
- Product ID
- 72603-171_04aaf2b3-3610-056f-e063-6394a90a91df
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Famotidine
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Labeler
- NorthStar Rx LLC
- Application
- ANDA215043
- Marketing category
- ANDA
- Marketing start
- 2023-09-07
- Substance
- FAMOTIDINE
- Active strength
- 40 mg/5mL
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Famotidine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FAMOTIDINE | 40 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5QZO15J2Z8 |
| Rxcui | 310274 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72603-171-01 | Famotidine | 50 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 50 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72603-171 | FAMOTIDINE POWDER, FOR SUSPENSION [NORTHSTAR RX LLC] | 1 | Current NDC, 1 package rows | 20230914_04aaf296-f136-29d7-e063-6294a90affe1.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72603-171-01 | 72603017101 | 50 mL in 1 BOTTLE (72603-171-01) | 50 ml | 2023-09-07 | No | No | Historical |